206.30
206.30 (0%)
As of Feb 14, 2025
Danaher Corp [DHR]
Source:
Company Overview
Danaher is a global science and technology innovator committed to accelerating the power of science and technology to improve human health. Danaher is comprised of more than 15 operating companies with leadership positions in the biotechnology, life sciences and diagnostics sectors, organized under three segments (Biotechnology, Life Sciences and Diagnostics).
| Country | United States |
| Headquarters | washington, district of columbia |
| Phone Number | (202) 828-0850 |
| Industry | manufacturing |
| CEO | Danaher Corp /De/ |
| Website | www.danaher.com |
Financial Year:
Financial Overview (Dollars in Millions)
| Revenue | $23,875 |
| Operating Profit | $4,863 |
| Net Income | $3,899 |
| Net Cash | $-3,786 |
Profit Ratios
| Gross Margin | $14,206 |
| Operating Margin | 20.4 |
| Profit as % of Revenues | 364.4% |
| Profit as % of Assets | 4.8% |
| Profit as % of Stockholder Equity | 7.9% |
Management Effectiveness
| Return on Equity | 7.9% |
| Return on Assets | 5% |
| Turnover Ratio | 29.5% |
| EBITA | $4,863 |
Balance Sheet and Cash Flow Measures
| Total Assets | $77,542 |
| Total Liabilities | $27,992 |
| Operating Cash Flow | $6,688 |
| Investing Cash Flow | $-1,981 |
| Financing Cash Flow | $-8,385 |
